Adjuvant Chemotherapy for Colon Cancer
Author and Disclosure Information [Show]

James N. Gerson, MD
Fellow, Hematology/Oncology, Temple University Hospital/Fox Chase Cancer Center, Philadelphia PA

Efrat Dotan, MD
Assistant Professor, Gastrointestinal Malignancies, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia PA

Question 1 of 5

A 37-year-old man presents to the emergency department with acute onset abdominal pain. Computed tomography (CT) of the abdomen and pelvis demonstrates a 3.5-cm mass in the transverse colon associated with bowel obstruction. CT of the chest is negative for metastatic disease. He is taken to the operating room and undergoes resection of the mass. Pathology confirms a 4 × 3.8 cm adenocarcinoma with extension into the muscularis propria, 3/17 positive nodes, and uninvolved proximal, distal, and radial margins. Tumor is found to be proficient in mismatch repair (MMR). The patient recovers and is discharged. He is referred to medical oncology for further management.

What is the most appropriate next step in management?

5-Fluorouracil and leucovorin for 6 months

Capecitabine for 3 months

FOLFOX (leucovorin, fluorouracil, oxaliplatin) for 6 months

Observation

Hospital Physician: Hematology/Oncology. 2017 July;12(4)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology

QUIZ

Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Management of Metastatic Gastric Cancer
Transfusion Medicine
Small Cell Lung Cancer
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Acute Myeloid Leukemia
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Clinical Management
Von Willebrand Disease: Assessment and Diagnostic Testing
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease